scholarly article | Q13442814 |
P819 | ADS bibcode | 1992PNAS...8910729F |
P356 | DOI | 10.1073/PNAS.89.22.10729 |
P8608 | Fatcat ID | release_5a5ryrsalfbaxl7xvf7yfnwfn4 |
P953 | full work available at URL | https://europepmc.org/articles/PMC50415 |
https://europepmc.org/articles/PMC50415?pdf=render | ||
P932 | PMC publication ID | 50415 |
P698 | PubMed publication ID | 1438269 |
P5875 | ResearchGate publication ID | 21717987 |
P2093 | author name string | D. W. Chung | |
E. W. Davie | |||
P. Thiagarajan | |||
D. H. Farrell | |||
P2860 | cites work | gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors | Q24301146 |
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Carboxy-terminal amino acid sequence of a human fibrinogen .gamma.-chain variant (.gamma.') | Q70997288 | ||
A model for fibrinogen: domains and sequence | Q93653228 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
Integrins: a family of cell surface receptors | Q28288125 | ||
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors | Q28645681 | ||
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
Exposure of platelet fibrinogen receptors by ADP and epinephrine | Q33473239 | ||
Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
Integrins | Q34174032 | ||
Arg-Gly-Asp: a versatile cell recognition signal | Q34382464 | ||
Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). | Q36404689 | ||
Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications | Q36614816 | ||
Characterization of a complementary deoxyribonucleic acid coding for the alpha chain of human fibrinogen. | Q36623127 | ||
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets | Q37556824 | ||
Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis | Q38330466 | ||
The ability of fibrinogen fragments to support ADP-induced platelet aggregation | Q39903313 | ||
Human platelets possess an inducible and saturable receptor specific for fibrinogen | Q41629256 | ||
Recombinant human fibrinogen and sulfation of the gamma' chain | Q41662631 | ||
The amino acid sequence of the alpha-chain of human fibrinogen | Q41700599 | ||
Characterization of the gamma chain platelet binding site on fibrinogen fragment D | Q42139757 | ||
Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis | Q42646476 | ||
A discrete sequence in a platelet integrin is involved in ligand recognition | Q43578287 | ||
Designation of sequences involved in the “coiled-coil” interdomainal connections in fibrinogen: Construction of an atomic scale model | Q44031652 | ||
Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor | Q46057359 | ||
Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide | Q46297974 | ||
Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. | Q46653870 | ||
Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen | Q47293932 | ||
Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. | Q48386755 | ||
.gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processing | Q48388090 | ||
Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. | Q54748393 | ||
Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation | Q67555202 | ||
Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins | Q68813946 | ||
The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin | Q69108110 | ||
Isolation of human platelets by albumin gradient and gel filtration | Q69602434 | ||
Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen | Q69647818 | ||
The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets | Q69744757 | ||
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets | Q69871824 | ||
Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin | Q69873043 | ||
Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length | Q69994088 | ||
The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets | Q70101386 | ||
Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets | Q70181883 | ||
Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chain | Q70211601 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | platelet aggregation | Q14913634 |
P1104 | number of pages | 4 | |
P304 | page(s) | 10729-10732 | |
P577 | publication date | 1992-11-01 | |
1992-11-15 | |||
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Role of fibrinogen alpha and gamma chain sites in platelet aggregation | |
P478 | volume | 89 |
Q52330622 | 14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling. |
Q27653017 | A Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics |
Q33391496 | A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia |
Q46546710 | A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreading |
Q45171116 | A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3. |
Q24543028 | A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A. |
Q36328589 | Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin |
Q30442274 | Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK |
Q39462538 | Aggregation efficiency of activated normal or fixed platelets in a simple shear field: effect of shear and fibrinogen occupancy |
Q92143986 | Altered activation of integrin ɑIIbβ3 on platelets irradiated with ultraviolet C from pathogen-reducing xenon flash |
Q34411401 | Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. |
Q34949834 | Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study |
Q28344771 | Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation |
Q41861048 | Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. |
Q34070941 | Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. |
Q41946735 | Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity |
Q46811064 | Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). |
Q33846044 | DLBS1033, a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activities. |
Q35013677 | Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin. |
Q34158852 | Demystified...adhesion molecule deficiencies |
Q35533290 | Dynamic Regulation of Fibrinogen: Integrin αIIbβ3 Binding |
Q34018917 | Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation |
Q33554510 | Effects of the RGD loop and C-terminus of rhodostomin on regulating integrin αIIbβ3 recognition |
Q34173198 | Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow |
Q39418485 | Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation and mass spectrometry |
Q33338109 | Extracellular matrix molecules as targets for brown spider venom toxins |
Q36492191 | Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction |
Q57116809 | Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site |
Q38801276 | Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection |
Q71822501 | Fibrinogen adsorption to receptor-like biomaterials made by pre-adsorbing peptides to polystyrene substrates |
Q36101288 | Fibrinogen and fibrin. |
Q33375883 | Fibrinogen and von Willebrand factor mediated platelet adhesion to polystyrene under flow conditions |
Q26866370 | Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing |
Q73174716 | Fibroblasts spread on immobilized fibrin monomer by mobilizing a beta1-class integrin, together with a vitronectin receptor alphavbeta3 on their surface |
Q72588960 | Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets |
Q59287671 | Glycoprotein lib peptide 656-667 mimics the fibrinogen γ chain 402-411 binding site on platelet integrin GPIIb/IIIa |
Q35979222 | Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer |
Q47844689 | Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen |
Q41125713 | Immunocytochemical aspects of platelet membrane glycoproteins and adhesive proteins during activation. |
Q37087346 | Immunological identification of fibrinogen in dual-component protein films by AFM imaging |
Q28610108 | Integrin alpha(IIb)beta(3) signaling in platelet adhesion and aggregation |
Q33252264 | Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling |
Q38644725 | Integrin αIIbβ3 outside-in signaling. |
Q73127962 | Interaction of beta 3 integrin-derived peptides 214-218 and 217-231 with alpha IIb beta 3 complex and with fibrinogen A alpha-chain |
Q42981591 | Interactions of integrin GPIIb/IIIa-derived peptides with fibrinogen investigated by NMR spectroscopy |
Q47806773 | Introducing multiple bio-functional groups on the poly(ether sulfone) membrane substrate to fabricate an effective antithrombotic bio-interface |
Q41481792 | Ligand binding and affinity modulation of integrins |
Q33401554 | Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity |
Q34075194 | Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker |
Q42620251 | Mass spectrometric mapping of fibrinogen conformations at poly(ethylene terephthalate) interfaces |
Q48045448 | Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin αIIbβ3. |
Q36277822 | Modeling the alpha IIb beta 3 integrin solution conformation. |
Q54735689 | Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa. |
Q40640829 | New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen |
Q36125413 | New circulating biomarkers for predicting cardiovascular death in healthy population. |
Q42365100 | Novel Mutations in the GPIIb and GPIIIa Genes in Glanzmann Thrombasthenia |
Q37211068 | PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE. |
Q48017537 | Peptide LSARLAF activates alpha(IIb)beta3 on resting platelets and causes resting platelet aggregate formation without platelet shape change |
Q77841213 | Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses |
Q56944972 | Platelet GPIIb-IIIa blockers |
Q74551383 | Platelet aggregation in flow: differential roles for adhesive receptors and ligands |
Q34496409 | Platelet integrin alphaIIbbeta3-ligand interactions: what can we learn from the structure? |
Q41975301 | Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide R |
Q33490246 | Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion |
Q28828698 | Proteins, platelets, and blood coagulation at biomaterial interfaces |
Q32031066 | Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom |
Q89982458 | Putative β-barrel outer membrane proteins of the bovine digital dermatitis-associated treponemes: identification, functional characterisation and immunogenicity |
Q74587116 | Reactivity of human platelets with immobilized fibrinogen is dictated by the chemical character of the surface |
Q38502611 | Regulation of integrins in platelets |
Q45884462 | Role of G protein signaling in the formation of the fibrin(ogen)-integrin αIIbβ3-actin cytoskeleton complex in platelets. |
Q47963220 | Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads |
Q33948050 | SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain |
Q56766048 | Secretion of biologically active recombinant fibrinogen by yeast |
Q27636935 | Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3 |
Q37071125 | Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller |
Q35438892 | Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains |
Q73803111 | Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin |
Q27651670 | Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin α IIb β 3 |
Q24309459 | Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction |
Q24536159 | Structure and function of the platelet integrin alphaIIbbeta3 |
Q27620960 | Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization |
Q41091026 | Supramolecular assemblies of a conjugate of nucleobase, amino acids, and saccharide act as agonists for proliferation of embryonic stem cells and development of zygotes |
Q74061144 | The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation |
Q47776821 | The Anti-aggregating Peptide KRDS Impairs a-granule Release, Whereas RGDS Does Not |
Q33381441 | The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend |
Q35921137 | The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen |
Q81424116 | The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury |
Q77910446 | The fibrinogen RIBS-I epitope (gamma373-385) appears proximate to the gamma408-411 adhesive domain but is not involved in interaction between receptor-bound or surface-adsorbed fibrinogen and platelet GPIIbIIIa |
Q74326032 | The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site |
Q43135408 | The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation. |
Q41941084 | The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanki |
Q35066799 | The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain |
Q34675284 | The pharmacodynamics of parenteral glycoprotein IIb/IIIa inhibitors |
Q42961262 | The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen |
Q73692244 | The polymerization pocket "a" within the carboxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site |
Q27740048 | The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro |
Q73617952 | The role of putative fibrinogen Aalpha-, Bbeta-, and GammaA-chain integrin binding sites in endothelial cell-mediated clot retraction |
Q28506063 | The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma |
Q33401995 | The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia |
Q27729409 | Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization |
Q40159483 | Time and force dependence of the rupture of glycoprotein IIb-IIIa-fibrinogen bonds between latex spheres |
Q71144329 | Variabilin, a novel RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis |
Q52007870 | Variations in the ability of adsorbed fibrinogen to mediate platelet adhesion to polystyrene‐based materials: A multivariate statistical analysis of antibody binding to the platelet binding sites of fibrinogen |
Q84492404 | Why dysfibrinogenaemias still matter |
Q40455189 | [New reflections on inflammation and coagulation]. |
Q89777927 | αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible |
Q36744522 | β-Subunit Binding Is Sufficient for Ligands to Open the Integrin αIIbβ3 Headpiece |
Search more.